Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine) (Atgam)
Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine) is an FDA-licensed reference biologic from Pharmacia & Upjohn Company LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1996
Reference approved
Reference product
Atgam Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine)
Pharmacia & Upjohn Company LLC
- Approved
- Dec 04, 1996
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine), in chronological order.
Reference approval
Approval date of the reference Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine) product.
29 yr 11 mo ago
Frequently asked questions
Are there biosimilars approved for Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine) (Atgam)?
No 351(k) biosimilars or interchangeable biosimilars referencing Lymphocyte Immune Globulin, Anti-thymocyte Globulin (Equine) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.